Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation
Hijazi, Ziad , Aulin, Julia , Andersson, Ulrika , Alexander, John H. , Granger, Christopher B. , Hanna, Michael G. , Horowitz, John D. , Siegbahn, Agneta , Wallentin, Lars , Gersh, Bernard J. , Hylek, Elaine M. , Lópes, Renato D. , Granger, Christopher B

Heart | February 14, 2016 | Volume: 102 | Issue: 7 | Pages: 508-517

10.1136/heartjnl-2015-308887 | PMID 26839066 Get It

Objective Atrial fibrillation (AF) is a risk factor for stroke and mortality and the prothrombotic state has been linked to inflammation. In this study we evaluated the relationship between inflammatory biomarkers at baseline and future risk of cardiovascular events in the Apixaban for Reduction In Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Methods The ARISTOTLE trial randomised 18 201 patients with AF to apixaban or warfarin. Interleukin 6 (IL-6) and C reactive protein (CRP) were analysed in plasma obtained at randomisation from 14 954 participants, and median follow-up was 1.9 years. Association between quartile groups of IL-6 and CRP and outcomes were analysed by Cox regression adjusted for clinical risk factors and other cardiovascular biomarkers (NT-proBNP, troponin, GDF-15, cystatin C). Results The IL-6 median level was 2.3 ng/L (IQR 1.5–3.9), median CRP level was 2.2 mg/L (1.0–4.8). IL-6 and CRP were significantly associated with all-cause mortality independent of clinical risk factors and other biomarkers (HR (95% CI) 1.93 (1.57 to 2.37) and 1.49 (1.24 to 1.79), respectively, Q4 vs Q1). IL-6 was associated with myocardial infarction, cardiovascular mortality, and major bleeding beyond clinical risk factors but not in the presence of cardiovascular biomarkers (NT-proBNP, troponin, GDF-15, cystatin C). Neither inflammatory biomarker was associated with stroke/systemic embolism. Risk prediction for stroke, death and major bleeding was not improved by IL-6 or CRP when added to clinical risk factors and the other cardiovascular biomarkers (NT-proBNP, troponin, GDF-15, cystatin C). Conclusions In patients with AF on anticoagulation, after accounting for clinical risk factors and other biomarkers, biomarkers of inflammation were significantly associated with an increased risk of mortality. However, there were no associations with the risk of stroke or major bleeding. Trial registration number ClinicalTrials.gov identifier: NCT00412984 post-results.
Spontaneous coronary artery dissection and its association with heritable connective tissue disorders
Negrotto, Sara , Kirmani, Salman , Deyle, David R. , Gulati, Rajiv , Olson, Timothy M. , Negrotto, Sara M, Tweet, Marysia S. , Henkin, Stanislav , Hayes, Sharonne N. , Olson, Timothy M

Heart | February 14, 2016 | Volume: 102 | Issue: 11 | Pages: 876-881

10.1136/heartjnl-2015-308645 | PMID 26864667 Get It

Objective Spontaneous coronary artery dissection (SCAD) is an under-recognised but important cause of myocardial infarction and sudden cardiac death. We sought to determine the role of medical and molecular genetic screening for connective tissue disorders in patients with SCAD. Methods We performed a single-centre retrospective descriptive analysis of patients with spontaneous coronary artery disease who had undergone medical genetics evaluation 1984–2014 (n=116). The presence or absence of traits suggestive of heritable connective tissue disease was extracted. Genetic testing for connective tissue disorders and/or aortopathies, if performed, is also reported. Results Of the 116 patients (mean age 44.2 years, 94.8% women and 41.4% with non-coronary fibromuscular dysplasia (FMD)), 59 patients underwent genetic testing, of whom 3 (5.1%) received a diagnosis of connective tissue disorder: a 50-year-old man with Marfan syndrome; a 43-year-old woman with vascular Ehlers–Danlos syndrome and FMD; and a 45-year-old woman with vascular Ehlers–Danlos syndrome. An additional 12 patients (20.3%) had variants of unknown significance, none of which was thought to be a definite disease-causing mutation based on in silico analyses. Conclusions Only a minority of patients with SCAD who undergo genetic evaluation have a likely pathogenic mutation identified on gene panel testing. Even fewer exhibit clinical features of connective tissue disorder. These findings underscore the need for further studies to elucidate the molecular mechanisms of SCAD.
The spectrum of low-output low-gradient aortic stenosis with normal ejection fraction
Pislaru, Sorin V. , Pellikka, Patricia A. , Sabbah, Michael S. , Pellikka, Patricia A

Heart | February 14, 2016 | Volume: 102 | Issue: 9 | Pages: 665-671

10.1136/heartjnl-2015-307893 | PMID 26822426 Get It

Low-flow, low-gradient (LF/LG) severe aortic stenosis (AS) with preserved ejection fraction refers to the condition of AS with aortic valve area ≤1 cm2, stroke volume index <35 mL/m2, mean aortic valve gradient <40 mm Hg and left ventricular ejection fraction ≥50%. This mismatch of aortic valve area suggesting severe stenosis and ‘low’ gradient in some patients has led to confusion as to the severity of stenosis. Conditions previously labelled as LF/LG severe AS include a spectrum, with measurement error probably being the most common cause of marked inconsistency between gradient, valve area and patient presentation. The presence of LG severe AS may be overestimated in petite patients, who may have aortic valve area slightly less than 1 cm2 with only moderate AS. Concomitant cardiac conditions besides AS, including significant mitral and tricuspid regurgitation, intracardiac shunts and constrictive pericarditis, may contribute to reduced stroke volume, and evidence for these must be sought at the time of echocardiography. True LF/LG severe AS is associated with a unique and probably maladaptive remodelling pattern with smaller ventricles, increasing relative wall thickness, progressive worsening of diastolic function and higher afterload, as demonstrated by lower systemic arterial compliance, higher systemic vascular resistance and higher valvuloarterial impedance. Control of hypertension is essential to the appropriate management of patients with AS. Aortic valve replacement should be considered in patients with compelling evidence of severe AS who remain symptomatic despite optimal treatment of hypertension.
Epigenetic Studies Point to DNA Replication/Repair Genes as a Basis for the Heritable Nature of Long Term Complications in Diabetes
Leontovich, Alexey A. , Intine, Robert V., Sarras, Michael P.

Journal of Diabetes Research | February 14, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-10

10.1155/2016/2860780 | PMID 26981540 Get It

Metabolic memory (MM) is defined as the persistence of diabetic (DM) complications even after glycemic control is pharmacologically achieved. Using a zebrafish diabetic model that induces a MM state, we previously reported that, in this model, tissue dysfunction was of a heritable nature based on cell proliferation studies in limb tissue and this correlated with epigenetic DNA methylation changes that paralleled alterations in gene expression. In the current study, control, DM, and MM excised fin tissues were further analyzed by MeDIP sequencing and microarray techniques. Bioinformatics analysis of the data found that genes of theDNA replication/DNA metabolism processgroup (with upregulation of theapex1, mcm2, mcm4, orc3,lig1, anddnmt1 genes) were altered in the DM state and these molecular changes continued into MM. Interestingly, DNA methylation changes could be found as far as 6–13 kb upstream of the transcription start site for these genes suggesting potential higher levels of epigenetic control. In conclusion, DNA methylation changes in members of theDNA replication/repair processgroup best explain the heritable nature of cell proliferation impairment found in the zebrafish DM/MM model. These results are consistent with human diabetic epigenetic studies and provide one explanation for the persistence of long term tissue complications as seen in diabetes.
Splenomegaly and thrombosis risk in essential thrombocythemia: the mayo clinic experience
Haider, Mahnur , Gangat, Naseema , Hanson, Curtis A. , Tefferi, Ayalew , Hanson, Curtis

American Journal of Hematology | February 14, 2016 | Volume: 91 | Issue: 5 | Pages: No page available

10.1002/ajh.24334 | PMID 26875150 Get It

Spur cell anemia in the setting of progressive liver allograft failure
Partain, Daniel K. , Poterucha, John J., Ashrani, Aneel A. , Thompson, Carrie A. , Botero, Juliana Perez , Shi, Min , Partain, Daniel K

American Journal of Hematology | February 14, 2016 | Volume: 91 | Issue: 10 | Pages: 1061-1061

10.1002/ajh.24331 | PMID 26874796 Get It

Nodular Fasciitis of the Orbit: A Case Report Confirmed by Molecular Cytogenetic Analysis
Anzeljc, Andrew J., Oliveira, André M. , Kim, Hee Joon , Hayek, Brent , Grossniklaus, Hans E.

Ophthalmic Plastic & Reconstructive Surgery | February 14, 2016 | Volume: 33 | Issue: 3S | Pages: S152-S155

10.1097/iop.0000000000000649 | PMID 26882059 Get It

Nodular fasciitis is a benign fibroblastic proliferation typically found in the subcutaneous tissue or superficial fascia of the extremities that is often confused for malignancy. These lesions rarely occur on the eyelids and ocular adnexa and are seldom analyzed by ophthalmic pathologists. USP6 gene rearrangement has been recently demonstrated in nodular fasciitis and this rearrangement may lead to the formation of a fusion gene MYH9-USP6 in some cases. Herein, the authors describe a 38-year-old woman with a 6-month history of a progressively enlarging mass beneath her right medial upper eyelid. Histopathologic analysis of the excisional biopsy confirmed classic features of nodular fasciitis. Molecular cytogenetic analysis revealed a rearrangement of the USP6 locus, confirming the diagnosis of benign nodular fasciitis.
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS‐T) and the role of next‐generation sequencing
Patnaik, Mrinal M. , Finke, Christy M. , Hanson, Curtis A. , King, Rebecca L. , Ketterling, Rhett P. , Gangat, Naseema , Tefferi, Ayalew , Lasho, Terra L. , Ketterling, Rhett P

American Journal of Hematology | February 14, 2016 | Volume: 91 | Issue: 5 | Pages: 492-498

10.1002/ajh.24332 | PMID 26874914 Get It

Refractory anemia with ring sideroblasts and thrombocytosis (RARS‐T) shares overlapping features of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). RARS‐T is characterized by SF3B1 and JAK2 mutations and prognosis is considered to be better than MDS but not as good as MPN. The objective of the study was to identify predictors of survival in RARS‐T. We analyzed clinical and laboratory variables in 82 patients and applied a 27‐gene NGS assay to 48 marrow samples obtained at diagnosis. 94% of patients had ≥1 mutations; common mutations being: SF3B1 85%, JAK2 V617F 33%, ASXL1 29%, DNMT3A 13%, SETBP1 13% and TET2 10%. In a multivariable survival analysis ( n = 82), anemia ( P = 0.02) [HB< 10 gm/dl: HR 2.3, 95% CI 1.2–4.6] and abnormal karyotype ( P =.01) [HR 6.1, 95% CI 2.7‐13.8] were independently prognostic for inferior survival. In patients with NGS information ( n = 48), univariate analysis showed association between poor survival and presence of SETBP1 ( P = 0.04) or ASXL1 ( P = 0.08) mutations whereas the absence of these mutations ( ASXL1 wt/ SETBP1 wt) was favorable ( P = 0.04); the number of concurrent mutations did not provide additional prognostication ( P = 0.3). We developed a HR‐weighted prognostic model, with 2 points for an abnormal karyotype, 1 point for either ASXL1 and/or SETBP1 mutations, and 1 point for a HB level < 10 gm/dl, which effectively stratified patients into three risk categories; low (0 points), intermediate (1 point) and high (≥2 points), with median survivals of 80, 42 and 11 months respectively ( P = 0.01). In summary, we confirm the unique mutational landscape in RARS‐T and provide a novel mutation‐enhanced prognostic model. Am. J. Hematol. 91:492–498, 2016. © 2016 Wiley Periodicals, Inc.
Increased Operative Time for Benign Cranial Nerve Tumor Resection Correlates with Increased Morbidity Postoperatively
Murphy, Meghan E. , Gilder, Hannah E., McCutcheon, Brandon A., Kerezoudis, Panagiotis , Rinaldo, Lorenzo , Shepherd, Daniel , Maloney, Patrick R. , Snyder, Kendall, Carlson, Matthew L. , Link, Michael J., Bydon, Mohamad , Murphy, Meghan, Gilder, Hannah, Maloney, Patrick , Van Gompel, Jamie J, Carter, Bob S. , Gompel, Jamie J. Van

Journal of Neurological Surgery Part B: Skull Base | February 13, 2016 | Volume: 77 | Issue: 04 | Pages: 350-357

10.1055/s-0036-1572508 | PMID 27441161 Get It

Entrapment of a Pacing Lead within a Chiari Network: Utility of Intracardiac Echo and a Laser Sheath
Aung, Htin , Espinosa, Raúl E. , Powell, Brian D. , McLeod, Christopher J.

Pacing and Clinical Electrophysiology | February 13, 2016 | Volume: 39 | Issue: 6 | Pages: 620-622

10.1111/pace.12828 | PMID 26873294 Get It